Pyrrolobenzodiazepines, (PBD) are a class of compound that may have antibiotic or anti-tumor properties.[1]
Some dimeric pyrrolobenzodiazepines are used as the cytotoxic drug payloads in antibody-drug conjugates, for example in loncastuximab tesirine.
History
editAnthramycin, the first PBD monomer, was first synthesized in the 1960s.[2]
References
edit- ^ Hartley JA (June 2011). "The development of pyrrolobenzodiazepines as antitumour agents". Expert Opinion on Investigational Drugs. 20 (6): 733–44. doi:10.1517/13543784.2011.573477. PMID 21457108. S2CID 26275418.
- ^ Mantaj, Julia; Jackson, Paul J. M.; Rahman, Khondaker M.; Thurston, David E. (2017). "From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody–Drug Conjugates (ADCs)". Angewandte Chemie International Edition. 56 (2): 462–488. doi:10.1002/anie.201510610. PMID 27862776.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
 | This article about a heterocyclic compound is a stub. You can help Wikipedia by expanding it. |